EFFECTS OF LERGOTRILE ON SCHIZOPHRENIA AND DRUG-INDUCED PARKINSONISM

被引：0
|
作者：
SMALL, JG
KELLAMS, JJ
MILSTEIN, V
KLAPPER, M
LEMBERGER, L
机构：
[1] LARUE D CARTER MEM HOSP,DEPT PSYCHIAT,INDIANAPOLIS,IN
[2] LARUE D CARTER MEM HOSP,DEPT PHARMACOL,INDIANAPOLIS,IN
[3] LARUE D CARTER MEM HOSP,DEPT MED,INDIANAPOLIS,IN
[4] INDIANA UNIV,SCH MED,LILLY LAB CLIN RES,INDIANAPOLIS,IN 46202
来源：
COMMUNICATIONS IN PSYCHOPHARMACOLOGY | 1977年 / 1卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：461 / 467
页数：7
相关论文
共 50 条
  • [31] SUSCEPTIBILITY TO DRUG-INDUCED PARKINSONISM
    RAJPUT, AH
    ROZDILSKY, B
    HORNYKIEWICZ, O
    SHANNAK, K
    LEE, T
    SEEMAN, P
    NEUROLOGY, 1979, 29 (04) : 567 - 567
  • [32] Drug-induced parkinsonism with amiodarone
    Erdem, N. F.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (04) : S164 - S164
  • [33] DRUG-INDUCED SCHIZOPHRENIA
    HOFFER, A
    CALLBECK, MJ
    JOURNAL OF MENTAL SCIENCE, 1960, 106 (442): : 138 - 159
  • [34] UNSUSPECTED, SURREPTITIOUS DRUG-INDUCED PARKINSONISM
    ALBANESE, A
    COLOSIMO, C
    BENTIVOGLIO, AR
    BERGONZI, P
    NEUROLOGY, 1992, 42 (02) : 459 - 459
  • [35] HLA ANTIGENS IN DRUG-INDUCED PARKINSONISM
    METZER, WS
    NEWTON, JEO
    STEELE, RW
    CLAYBROOK, M
    PAIGE, SR
    MCMILLAN, DE
    HAYS, S
    MOVEMENT DISORDERS, 1989, 4 (02) : 121 - 128
  • [36] Drug-induced parkinsonism: diagnosis and management
    Blanchet, Pierre J.
    Kivenko, Veronika
    JOURNAL OF PARKINSONISM AND RESTLESS LEGS SYNDROME, 2016, 6
  • [37] DRUG-INDUCED PARKINSONISM - A GROWING LIST
    MASSO, JFM
    CARRERA, N
    URTASUN, M
    MOVEMENT DISORDERS, 1993, 8 (01) : 125 - 125
  • [38] DRUG-INDUCED PARKINSONISM AND SEBORRHEIC DERMATITIS
    不详
    PHARMACY INTERNATIONAL, 1983, 4 (10): : 256 - 256
  • [39] CALCIUM THERAPY IN DRUG-INDUCED PARKINSONISM
    LICHTIGFELD, FJ
    BRITISH JOURNAL OF PSYCHIATRY, 1965, 111 (470) : 197 - 198
  • [40] Drug-induced parkinsonism: diagnosis and treatment
    Conn, Hannah
    Jankovic, Joseph
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (12) : 1503 - 1513
12345